![]() In commercially available droplet dPCR, the droplets have to be transferred manually, leading to underestimation of the targets. The shift from droplet to chip-based technology for the diagnosis of various diseases has been pivotal in the advancement of the devices. Shift of Healthcare Providers from Droplet to Chip-based Technology to Boost Market Request a Free sample to learn more about this report. The growth is attributed to the increased adoption of devices in diagnostics centers for the diagnosis of COVID-19. The market players witnessed growth in revenue generated during 2020.įor instance, Bio-Rad Laboratories, Inc., a key player in the market, registered a revenue of USD 2,545.6 million in 2020, an increase of 10.1% as compared to 2019. Additionally, during the initial days of the pandemic, the resources were devoted to fighting the coronavirus pandemic due to the strong infectious nature of the disease. ![]() Furthermore, the positive impact was due to the strong increase in COVID-19 testing in high-burden countries across the world. The reallocation of healthcare resources for COVID-19 treatment increased the number of people going for the COVID-19 diagnosis and increased the adoption of the device in diagnostic centers and research institutes, thereby fueling the demand for the devices. The global digital PCR market witnessed a humongous growth rate of 38.6% in 2020 as compared to 18.1% in 2019. This is attributed to the vast spread of the virus, thereby increasing the demand for effective diagnostics to control its spread. The impact of COVID-19 resulted in considerably high growth of the market in 2020. COVID-19 IMPACTĬOVID-19 Pandemic Propelled the Market Growth due to Increase in SARS CoV-2 Testing ![]() Moreover, rising technological advancements in digital devices are projected to contribute to the market growth during the forecast period. The rise in prevalence of infectious diseases, cancer, and genetic disorders, the introduction of products, increasing acquisitions, and the growing adoption of digital devices by laboratories are some of the key factors expected to drive the market growth during the forecast period. It is a high-throughput absolute quantitative method that provides a sensitive and reproducible way of measuring the amount of DNA or RNA in a sample. The global COVID-19 pandemic has been unprecedented and staggering, with digital PCR experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.Ī digital polymerase chain reaction (dPCR) is a biotechnological advancement of conventional polymerase chain reaction. Based on our analysis, the global market exhibited a higher growth of 38.6% in 2020 as compared to 2019. The global digital PCR market size was valued at USD 428.7 million in 2021 and is projected to grow from USD 413.0 million in 2022 to USD 1,847.0 million by 2029, exhibiting a CAGR of 23.9% during the forecast period. ![]()
0 Comments
Leave a Reply. |